103
provision on interaction with immune mechanisms: the development of oncology causes both an innate
immunity response - a reaction to the appearance of a mutation in the cell, and the acquired one - to correct
the onset of an immune response by forming lymphocyte cells that fight the tumor antigen. Also B cells. The
participation of B cells in antitumor immunity can manifest itself in several ways: destruction of tumor cells
with antibodies fixing complement; accumulation of NK cells, release on their surface of cytophilic
antibodies;
Natural killers. Another type of cells that carry out immunological surveillance and participate in the
destruction of transformed cells are NK. They belong to lymphoid cells, but they do not have markers of T
and B lymphocytes. The set of cells exposed to the lactic action of NK is quite wide. This is a series of virus-
infected and opaque cells, cells on the surface of which are represented by cytophilic antibodies, embryonic
cells. Despite the fact that NC morphologically resemble lymphocytes or lymphoblasts, their histogenetic
association with T- or B-lymphocytes has not been established. Probably, NK belongs to an independent line
of differentiation, although at the earliest stages of development they have a common precursor with
lymphocytes. NK have no antigen-knowing receptors, do not exhort themselves after with an alien antigen
and are not capable of forming immunological memory. At the same time, their activity is increased by the
transfer of T-cell cytokines and, first of all, interleukin-γ. The study of the problems of the development and
usefulness of the mechanisms and reactions of immunity against tumors is very important at the present time.
The aggravation of the ecology, the quality of nutrition and water leads to the achievement of a number of
cancer patients.
Supervisors: Candidate of Biological Sciences, Associate Professor, Zakiryanova G.K., Candidate of
Biological Sciences, Associate Professor, Ablaikhanova N.T.
Достарыңызбен бөлісу: